100 Participants Needed

Predictive Tests for Stress Urinary Incontinence After Pelvic Organ Prolapse Surgery

Recruiting at 2 trial locations
ML
Overseen ByMaryse Larouche, MD, MPH
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to predict and prevent stress urinary incontinence (urine leakage during activities like coughing) that may occur after pelvic organ prolapse surgery. It compares two methods: a preoperative test where a doctor checks for leaks when a patient coughs (Preoperative Prolapse Reduction Cough Stress Test) and an intraoperative maneuver that checks for leaks during surgery (Intraoperative Crede Manoeuver). The trial aims to determine which method better predicts and prevents urinary issues, thereby improving patients' quality of life. Women with significant pelvic organ prolapse requiring surgery, but without a history of stress urinary incontinence, might be suitable candidates for this trial. As an unphased trial, this study provides an opportunity to contribute to important research that could enhance surgical outcomes and quality of life for future patients.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these methods are safe for predicting stress urinary incontinence?

Research has shown that the intraoperative Crede maneuver is generally safe. This technique involves gently pressing on the bladder during surgery to check for urine leaks. Studies have found it to be a simple and safe method.

The preoperative prolapse reduction cough stress test is another safe and straightforward procedure performed before surgery. In this test, a healthcare provider checks for urine leaks by having the patient cough while gently pushing back any bulging pelvic organs.

Both methods help predict and prevent urinary incontinence (loss of bladder control) after surgery. Reports of significant problems with either technique are absent, making them well-tolerated options.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it seeks to improve the decision-making process during pelvic organ prolapse surgery, particularly in determining the need for additional anti-incontinence procedures. Traditionally, stress urinary incontinence is managed with surgeries like sling procedures, but identifying patients who will benefit from these interventions can be challenging. The trial evaluates methods like the preoperative prolapse reduction cough stress test and the intraoperative Crede maneuver, which aim to predict incontinence risk more accurately. By enhancing predictive accuracy, these techniques could lead to more tailored and effective surgical plans, potentially reducing unnecessary procedures and improving patient outcomes.

What evidence suggests that these methods are effective for predicting stress urinary incontinence after pelvic organ prolapse surgery?

In this trial, participants will undergo one of two predictive tests for stress urinary incontinence (SUI) following pelvic organ prolapse surgery. Research has shown that the intraoperative Crede maneuver, one of the tests in this trial, can predict SUI. Specifically, one study indicated it predicted SUI in about 32.5% of women after surgery, suggesting its usefulness in deciding whether to perform additional procedures during surgery to prevent incontinence. The other test, the preoperative prolapse reduction cough stress test, is used before surgery to check for signs of SUI. These tests assist doctors in determining if preventive steps are needed before surgery. Both methods aim to reduce the risk of developing urinary incontinence post-surgery.12367

Who Is on the Research Team?

ML

Maryse Larouche, MD, MPH

Principal Investigator

St. Mary's Research Centre and RI-MUHC

Are You a Good Fit for This Trial?

This trial is for women with a prolapse condition (anterior, uterine or apical) that's at least moderate in severity and needs surgery. It's not for those who are pregnant, don't speak English or French, have only posterior prolapse, can't attend follow-up visits, already have stress urinary incontinence, or had previous surgeries for incontinence or urethral repair.

Inclusion Criteria

I need surgery for a significant pelvic organ prolapse.

Exclusion Criteria

I experience urine leakage when I cough, sneeze, or exercise.
My condition is a prolapse affecting only the back wall of my vagina.
I have had surgery to repair my urethra.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preoperative Assessment

Participants undergo preoperative prolapse reduction cough stress test to determine eligibility for anti-incontinence procedure

1 visit
1 visit (in-person)

Surgical Intervention

Participants undergo POP surgical repair and intraoperative Crede maneuver to assess PONSUI risk and determine need for anti-incontinence procedure

1 day
1 visit (in-person)

Postoperative Follow-up

Participants are monitored for safety, effectiveness, and complications after surgery, including assessments at 6 weeks and 6 months

6 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Intraoperative Crede Manoeuver
  • Preoperative Prolapse Reduction Cough Stress Test
Trial Overview The CREDE study is testing two methods to predict and prevent new-onset stress urinary incontinence after pelvic organ prolapse surgery: the intraoperative Crede manoeuver versus a preoperative cough test. The impact on patient outcomes and quality of life will also be assessed.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intraoperative Crede manoeuverExperimental Treatment1 Intervention
Group II: Preoperative prolapse reduction cough stress testActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

Trials
476
Recruited
170,000+

St. Mary's Research Centre, Montreal

Collaborator

Trials
1
Recruited
100+

Published Research Related to This Trial

The study involved 137 women and found a significant association between occult incontinence and the risk of developing postoperative stress urinary incontinence (POSUI) after pelvic organ prolapse surgery.
Despite the association, the tests used to identify women at risk for POSUI showed poor predictive performance at the individual level, indicating that occult incontinence alone is not a reliable indicator for recommending prophylactic anti-incontinence procedures.
Occult incontinence as predictor for postoperative stress urinary incontinence following pelvic organ prolapse surgery.Svenningsen, R., Borstad, E., Spydslaug, AE., et al.[2022]
Surgeons certified in female pelvic medicine and reconstructive surgery (FPMRS) performed more anti-incontinence procedures and were more likely to complete essential perioperative tasks compared to non-FPMRS surgeons, indicating a higher standard of care.
Patients operated on by FPMRS-certified surgeons experienced fewer readmissions within 30 days post-surgery, suggesting that these specialists may provide safer and more effective surgical outcomes for stress urinary incontinence.
Performance of Perioperative Tasks for Women Undergoing Anti-incontinence Surgery: Developed by the AUGS Quality Improvement and Outcomes Research Network.Erekson, E., Whitcomb, EL., Kamdar, N., et al.[2023]
In a study of 103 patients who underwent surgery for genitourinary prolapse, 86% of those who experienced incontinence shortly after surgery continued to be incontinent long-term, regardless of their urodynamic assessment results.
The study found that postoperative urodynamic assessments did not reliably predict bladder function or correlate with patient-reported symptoms, suggesting that postoperative symptoms are a better indicator of surgical success than urodynamic parameters.
[Value of postoperative urodynamic assessment for long-term urinary function results after treatment of genital prolapse. 103 examinations after treatment of genital prolapse].Therby, D., Viala, F., Cosson, M., et al.[2006]

Citations

CREDE Study: Intraoperative Crede Manoeuver Compared ...The CREDE pilot randomized study will compare the intraoperative Crede manoeuver (M1) to preoperative prolapse (POP) reduction cough stress ...
The Intra-Operative Crede Maneuver to Detect Latent ...Crede was negative in 52 (67.5%) women, and positive in 25 (32.5%) (MUS placed in 21 women). Rate of postoperative de novo SUI (symptoms or retreatment) at 1.9 ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/24165452/
Intraoperative Crede maneuver for tape adjustment during ...Conclusion: Using CM for intraoperative tape adjustment does not improve continence rates compared to the traditional method of TOT sling placement. MeSH terms.
Predictive Tests for Stress Urinary Incontinence After Pelvic ...The Intraoperative Crede Manoeuver is unique because it involves a manual technique performed during surgery to help predict stress urinary incontinence after ...
Adjustment of tension applied in transobturator tapes ...Intraoperative adjustment of tension using Valsalva maneuver under saddle anesthesia gives better outcomes than the conventional tension-free technique.
The Intra-Operative Crede Maneuver to Detect Latent ...The Intra-Operative Crede Maneuver to Detect Latent Stress Urinary Incontinence—Technique and Outcomes. May 2022; Journal of Obstetrics and ...
Adjustment of tension applied in transobturator tapes in...Intraoperative adjustment of tension using Valsalva maneuver under saddle anesthesia gives better outcomes than the conventional tension-free technique.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security